AREVA Blog - North America

Browse by Tags

• Alpha-RIT
• AREVA Inc.
• AREVA Med
• AREVA Med LLC
• AREVA News
• AREVA North America
• Cancer Treatments
• France
• Jacques Besnainou
• La Hague
• National Cancer Institute
• News
• Nuclear Energy
• Nuclear Power
• Patrick Bourdet
• TF1

• AREVA to Build Facility for Medical Isotope Production

  AREVA Med, an AREVA subsidiary, announced today the future construction of a facility in France that will produce on a large-scale medical grade lead 212. Why Lead-212? Lead-212 is a rare radioactive isotope that lies at the heart of promising nuclear medical research to develop new cancer treatments. Over the past few years, AREVA Med and [...] Read More... Posted Mar 10 2010, 05:04 PM by AREVA North America: Next Energy Blog Filed under: Nuclear Energy, News, Nuclear Medicine, AREVA News

• Check out AREVA Med Online

  p>We have discussed our efforts in nuclear medicine and the AREVA Med project a couple of times on the blog before, and now I am very pleased tell you about our new website, www.arevamed.com. Here you will be able to discover more information on the project’s history, basic and technical merit. Through innovation, AREVA Med is [...] Read More... Posted Dec 23 2009, 08:18 AM by AREVA Blog - North America Filed under: Nuclear Power, Nuclear Energy, AREVA North America, AREVA Inc., News, Nuclear Medicine, AREVA Med, Patrick Bourdet

• A Look at AREVA’s Work for the Advancement of Nuclear Medicine

  by Katherine Berezowskyj Last week France’s TF1 television network featured AREVA’s innovative work under way in partnership with the U.S. National Cancer Institute and the University of Alabama for the development of a treatment to fight cancer. The news team got to take a look inside AREVA’s La Hague Facility, in Normandy, where the idea of using [...] Read More... Posted Nov 10 2009, 12:30 PM by AREVA Blog - North America Filed under: Nuclear Power, Nuclear Energy, AREVA North America, AREVA Inc., La Hague, Nuclear Medicine, France, TF1, Alpha-RIT, AREVA Med

• AREVA Med CEO Interview

  And if the AREVA Med recognition at the CGI event has you curious for more background on this effort, do see the interview with CEO Patrick Bourdet here: http://djysrv.blogspot.com/2009/05/areva-enters-nuclear-medicine-market.html Read More... Posted Sep 25 2009, 01:44 PM by AREVA Blog - North America Filed under: Nuclear Medicine

• Clinton Global Initiative Recognizes AREVA Med’s Efforts to Develop New Cancer Treatments

  Today in New York, the Clinton Global Initiative (CGI) recognized AREVA and its subsidiary AREVA Med LLC for its pioneering work in developing new methods for producing medical-grade Lead 212─ an isotope that could someday be used in promising cancer treatments. As the world leader in clean energy generation, AREVA has rather unique expertise in radiochemistry [...] Read More... Posted Sep 24 2009, 02:11 PM by AREVA Blog - North America Filed under: Nuclear Medicine

• AREVA Forms Med LLC to Develop Cancer Treatments

  Announced today, AREVA has formed a new company dedicated to the development of powerful new anti-cancer treatments. AREVA Med LLC will work to target aggressive forms of cancer that currently have limited treatment options. If successful in clinical trails, the new treatments would be used in advanced types of nuclear medicine, such as alpha [...] Read More... Posted May 08 2009, 03:48 PM by AREVA Blog - North America Filed under: AREVA North America, AREVA Inc., News, Jacques Besnainou, National Cancer Institute, Nuclear Medicine, AREVA Med LLC, Cancer Treatments